Shares of Zydus Lifesciences were trading in the red and 5% lower on 24 April after the company’s injectables production plant received ten observations from...
Shares of Zydus Lifesciences hit a 52-week high of Rs 893.75 on 16 February after the company announced receiving USFDA approval for Isosorbide Mononitrate Extended-Release...
Shares of Zydus Lifesciences Ltd surged after it informed the exchanges about its proposal for a Buyback plan. Further, the company will also announce its...
Shares of Zydus Lifesciences were trading almost 2% lower on 27 December after the company announced that its wholly-owned subsidiary Zydus Healthcare Ltd (ZHL) had...
Shares of Zydus Lifesciences hit a 52-week high of Rs 680 on 18 December after the company announced receiving final approval from the USFDA (United...
Zydus Lifesciences, on 15 December, announced that it had received approval from the USFDA (US Food and Drug Administration) to market a generic antiviral medication...
Shares of Zydus Lifescience were trading in the green and 1% higher on 6 December after the company’s US subsidiary, Sentynl Therapeutics, assumed full responsibility...
Shares of Zydus Lifesciences, on 6 December, announced that it had received final approval from the USFDA (United States Food and Drug Administration) for manufacturing...
Zydus Lifesciences, on 1 December, announced that it had received final approval from the USFDA (United States Food and Drug Administration) for its tablets that...